Stem Cells and COVID-19
Editat de Chandra P. Sharma, Devendra K. Agrawal, Finosh G. Thankamen Limba Engleză Paperback – 22 apr 2022
Both hematopoietic and mesenchymal stem cells are critical to better understand the response of immune system to coronavirus infection in both healthy and co-morbid conditions in the development of effective vaccines and immunotherapies.
- Focuses on diagnosis, treatment and prevention
- Presents different aspects to enable researchers in the field to move toward designing novel therapeutics in the treatment of COVID-19
- Provides coverage of challenges and future perspectives in this fast-moving field
Preț: 807.97 lei
Preț vechi: 887.88 lei
-9%
Puncte Express: 1212
Preț estimativ în valută:
142.84€ • 169.79$ • 123.94£
142.84€ • 169.79$ • 123.94£
Carte tipărită la comandă
Livrare economică 05-19 martie
Specificații
ISBN-13: 9780323899727
ISBN-10: 0323899722
Pagini: 248
Ilustrații: 60 illustrations (50 in full color)
Dimensiuni: 191 x 235 x 21 mm
Greutate: 0.53 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0323899722
Pagini: 248
Ilustrații: 60 illustrations (50 in full color)
Dimensiuni: 191 x 235 x 21 mm
Greutate: 0.53 kg
Editura: ELSEVIER SCIENCE
Cuprins
1. Introduction
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells – potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models – Validation, Management & Strategies
12. Therapy: present & future clinical perspective
2. Characteristics and Immunobiology of COVID19
3. Molecular Mechanism and translation approaches
4. Inflammatory multisystem syndrome in COVID19: Insights on off-target organ system in susceptible and recovering population
5. Cytokine storm and stem cell activation in unveiling potential targets for diagnosis and therapy
6. Mesenchymal and hematopoietic stem cells: Novel avenues in combating COVID19
7. Immunomodulatory properties of mesenchymal and hematopoietic stem cells – potential therapeutic target for COVID-19
8. COVID19 and acute myocardial injury: Stem cell driven tissue remodeling in COVID19 infection
9. Stem cell born signals and tissue regeneration in COVID19 infection
10. Stem cell transplantation COVID19 management: Translational possibilities and future
11. Therapeutic scale stem cell-derived exosomes for COVID - 19: Models – Validation, Management & Strategies
12. Therapy: present & future clinical perspective